Few companies in the drug-development space have offered game-changing potential for their patients quite like Vertex Pharmaceuticals (NASDAQ: VRTX). While all eyes are on COVID-19 vaccine stocks, Vertex is simply dominating the treatment landscape for cystic fibrosis (CF) -- a genetic disease characterized by thick mucus production that can obscure the lungs and pancreas. Although CF doesn't have a cure, Vertex has brought to market a number of gene-based treatments that are improving lung fu...

What can you make of the market’s standard disclaimer, ‘past performance cannot guarantee future returns.' Should you avoid every stock that has shown enormous growth in recent months? Or should you ignore it, and focus on the fast-appreciating equities? The savvy investor takes a smart middle path, treating stocks as individuals and evaluating them case by case. Past performance is no guarantee, but it can be an indicator, especially consistent, long-term performance. But that is only one part ...

The broad-based S&P 500 plunged into bear market territory faster than ever before, and regained all of its losses in record time. Small-cap stocks -- those with market caps between $300 million and $2 billion -- usually have more built-in risk than mid-cap and large-cap stocks, but offer exceptional upside potential if you hit on a game changer. As we move into 2021, the following three small-cap stocks all have the tools and intangibles to make you richer.

WSM vs. LOVE: Which Stock Is the Better Value Option?

STAMFORD, Conn., Jan. 06, 2021 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq:LOVE) (the “Company”) today announced that the Company is scheduled to participate in a fireside chat at the 2021 ICR Conference held virtually on Monday, January 11, 2021, at 12:30 pm Eastern Time. The fireside chat will be webcast live over the Internet and can be accessed on the Company’s Investor Relations website, investor.lovesac.com. An online archive will be available on that site following the presentation.A...

One of the easiest ways to "go green" in 2021 is to consider buying into cannabis multistate operator Cresco Labs (OTC: CRLBF). While it's possible we see some modestly eased restrictions on marijuana from the federal government, Cresco simply needs state-level legalizations and organic growth to thrive. Acquiring Origin House in January 2020 allowed Cresco to come into possession of a cannabis distribution license in California (the most lucrative pot market in the world).

Your $600 stimulus payout could be worth $1,800 or more if you buy into these high-growth companies.

Lovesac (LOVE) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.